Pet-yksikkö

Julkaisut 2009
Publications 2009

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aalto S et al. The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
2 Aalto S et al. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand (11C)PIB uptake using 30-in scanning data.
3 Borra RJH. Nonalcoholic Fatty Liver Disease in Obesity and Type 2 Diabetes. . Studies sing 1H MRS and PET .
4 Borra RJH et al. Nonalcoholic fatty liver disease: Rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging .
5 Brück A et al. A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinsons's disease shows nonlinear progression in the putamen.
6 Dilsizian V et al. PET myocardial perfusion and metabolism clinical imaging.
7 Farinha RJPC et al. Segmentation of striatal brain structures from high resolution PET images.
8 Forsback S et al. Alternative solvents for electrophilic synthesis of 6-(18F)fluoro-L-DOPA.
9 Frisoni GB et al. In vivo mapping of amyloid toxicity in Alzheimer disease.
10 Georgiadis SD et al. Kalman smoother based time-varying spectrum astimation of EEG during single agnet propofol anesthesia.
11 Goernig M et al. Comparison of current density viability imaging at rest with FDG-PET in patients after myocardial infarction.
12 Grönroos T et al. Imaging of hypoxia with PET-CT.
13 Haukkala J et al. 68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice.
14 Higuchi T et al. Combined reporter gene PET and iron oxide MRI for monitoring survial and localization of transplanted cells in the rat heart .
15 Higuchi T et al. Reporter gene PET for monitoring survival of transplanted endothelial progenitor cells in the rat heart after pretreatment with VEGF and atorvastatin .
16 Hirvonen J et al. Measurement of central mu-opioid receptor binding in vivo with PET and [11C] carfentanil: a test-retest study in healthy subjects.
17 Hirvonen J et al. Assessment of MAO-B occupancy in the brain with PET and (11C)-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
18 Hirvonen MM et al. C957T Polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.
19 Hirvonen MM et al. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo.
20 Honka M-J et al. The Pro12A1a polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.
21 Iozzo P et al. Contribution of glucose tolerance and gender to cardiac adiposity.
22 Jokinen P et al. Impaired cognitive performance in Parkinson´s disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.
23 Jokinen P et al. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson´s disease from healthy controls.
24 Kaitosaari T et al. Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: the STRIP Study.
25 Kajander S et al. Low radiation dose imaging of myocardial perfusion and coranary with a hybrid PET/CT scanner .
26 Kauhanen S. Positron Emission Tomography in the Diagnosis and Staging of Pancreatic and Neuroendocrine Tumors.
27 Kauhanen S et al. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
28 Kauhanen SP et al. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
29 Kiss J et al. Non-invasive diagnosis of acute mesenteric ischaemia using PET.
30 Knuuti J et al. Quantification of myocardial blood flow will reform detection of CAD .
31 Koivuviita N et al. Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatc coronary artery disease.
32 Komar G et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness.
33 Komar G et al. Comparison of 2D and 3D performance for FDG PET with different acquisition times in oncological patients.
34 Korkeila E et al. Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer.
35 Korkeila E et al. Reply: expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer.
36 Koskenvuo JW et al. Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance.
37 Kronström K et al. Does defense style or psychological mindedness predict treatment response in major depression?
38 Kudomi N et al. Non-invasive estimation of hepatic glucose uptake from [18F] FDG PET images using tissue-derived input functions.
39 Kudomi N et al. Parametric renal blood flow imaging using (15O)H2O and PET.
40 Laine M et al. Central executive function in mild cognitive impairment: A PET activation study.
41 Laitala VS et al. Coffee drinking in middle age is not associated with cognitive performance in old age.
42 Laitinen I, Knuuti J. Imaging of vulnerable plaque: Potential breakthrough or pipe dream? .
43 Laitinen I. Imaging of the Vulnerable Atherosclerotic Plaque. Pre-Clinical Evaluation of PET Tracers for Vascular Inflammation.
44 Laitinen I et al. Uptake of inflammatory cell marker (11C)PK11195 into mouse atherosclerotic plaques.
45 Laitinen I et al. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
46 Laitio RM et al. The effects of xenon anesthesia on the relationship between cerebral glucose metabolism and blood flow in healthy subjects: a positron emission tomography study .
47 Latva-Hirvelä J et al. Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis.
48 Latva-Hirvelä J et al. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
49 Laurila JP et al. Extracellular superoxide dismutase is a growth regulatory mediator of tissue injury recovery.
50 Lindholm P et al. Preliminary study of carbon-11 methionine PET in the evaluation of early response to therapy in advanced breast cancer.
51 Lindholm P et al. The role of PET/CT and current challenges in prostate cancer management.
52 Lindroos MM et al. Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation .
53 Lindroos MM et al. m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction .
54 Martikainen I. Brain Dopamine and Serotonin Receptors in the Perception of Pain. Positron Emission Tomography Studies in Healthy Subjects.
55 Martikainen IK et al. Differential associations between brain 5-HT1A receptor binding and response to pain versus touch.
56 Maunu J et al. Brain and ventricles in very low birth weight infants at term: A comparison among head circumference, ultrasound, and magnetic resonance imaging.
57 Menichetti L et al. Positron emission tomography and (18F)BPA: a perspective application to assess tumour extraction of boron in BNCT.
58 Merisaari H et al. Gaussian mixture model-based segmentation of MR images taken from premature infant brains.
59 Minn H et al. 18F-FDOPA: A multiple-target molecule.
60 Nekolla SG et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model.
61 Nesterov SV et al. Myocardial perfusion quantitation with 15 O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas TM) .
62 Noponen T et al. Circulatory effect of inhaled iloprost in the newborn preterm lamb.
63 Nucifora G et al. Prevalence of coronary artery disease assessed by multislice computed tomography coronary angiography in patients with paroxysmal or persistent atrial fibrillation.
64 Okello A et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.
65 Opie LH, Knuuti J. The adrenergic-fatty acid load in heart failure.
66 Raitakari OT et al. Pulse pressure in youth and carotid intima-media thickness in adulthood. The Cardiovascular Risk in Young Finns Study.
67 Reiman M et al. Diffusion tensor imaging of the inferior colliculus and brainstem auditory-evoked potentials in preterm infants.
68 Reiman M et al. Interleukin-6 -174 and -572 genotypes and the volume of deep gray matter in preterm infants.
69 Roivainen A et al. Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography.
70 Salo TM et al. Fractal scaling properties of heart rate dynamics and myocardial efficiency in dilated cardiomyopathy.
71 Salokangas RKR et al. Perceived negative attitude of others as an early sign of psychosis.
72 Saraste A et al. Nuclear cardiology needs new "blood".
73 Saraste A et al. Cardiovascular molecular imaging: an overview .
74 Saraste A et al. Eteiskorvakkeen katetrisulku .
75 Scheinin NM et al. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
76 Schrey A,. Free Flap Monitoring Using Oxygen Measurement and Positron Emission Tomography.
77 Schwaiger M et al. Myocardial innervation.
78 Seppälä J et al. Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
79 Sherif HM et al. Evaluation of a novel 18 F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats .
80 Siiskonen T et al. Excitation functions for proton-induced reactions on natural hafnium: Production of 177Lu for medical use.
81 Siiskonen T et al. Excitation functions of proton-induced reactions in (nat)Cu in the energy range 7-17MeV.
82 Simell O et al. Cohort profile: the STRIP study (special Turku coronary risk factor intervention project), an infancy-onset dietary and life-style intervention trial.
83 Tuunanen H et al. Response to letter regarding article, "Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy".
84 Tárkányi E et al. Excitation functions of 3He- and alpha-particle induced nuclear reactions on natSb for production of medically relevant 123I and 124I radioisotopes.
85 Ujula T et al. Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis.
86 Ukkonen H et al. Cardiovascular drug develpoment using radiopharmaceuticals .
87 Ukkonen H et al. The effect of right ventricular pacing on myocardial oxidative metabolism and efficiency: relation with left ventricular dyssynchrony.
88 Viljanen A. Effects of Weight Loss on Adipose Tissue, Liver and Heart Metabolism in Humans. Studies with PET, MRI ja MRS.
89 Viljanen APM et al. Effects of weight loss on liver free fatty acid uptake and hepatic insulin resistance.
90 Viljanen APM et al. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance.
91 Viljanen APM et al. Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults.
92 Viljanen APM et al. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects .
93 Vilkman H et al. The effects of lorazepam on extrastriatal dopamine D2/3-receptors - A double-blind randomized placebo-controlled PET study.
94 Virta JJ et al. Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease.
95 Virtanen J et al. Comparison of principal and independent component analysis in removing extracerebral interference from near-infrared spectroscopy signals.
96 Virtanen KA et al. Functional brown adipose tissue in healthy adults.
Julkaisutietokanta 26.8.2010 Publications Data Base 26.8.2010